Chinese IBD Physician Survey on 5-ASA Use in Crohn's Disease

A survey of 615 inflammatory bowel disease physicians in mainland China regarding their perspectives and clinical practice patterns for using 5-aminosalicylic acid in Crohn's disease treatment. The dataset includes responses on prescription frequencies, indications, dosages, and rationales, collected via a 21-item questionnaire distributed through WeChat. The data was authored by Yuanli Li and last updated on 2026-04-27.

Use Cases

• Analyze prescription patterns for 5-ASA based on disease severity and phenotype mentioned in the description
• Study physician rationales for medication use based on cited safety and efficacy perceptions
• Investigate discrepancies between clinical guidelines and real-world practice based on survey results

Strengths

• Survey includes 615 respondents, providing a substantial sample size.
• Questionnaire was pilot-tested among 30 clinicians to ensure clarity and validity.
• Responses were anonymized and duplicate submissions were prevented via account verification.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data reflects a specific geographic and temporal context, which may limit generalizability.

Provenance

Source

Survey distributed via WeChat to IBD physicians across mainland China.

Collection Method

A 21-item questionnaire, with statistical analysis using the chi-square test.

Freshness

Last updated 2026-04-27 04:11:16; freshness should be verified.

Geography

Mainland China